At the news
? BEARISHIMPACT 5/10 144 filed Aug 10, 2026 at 16:49 ET
CEO Dinesh Patel filed a Form 144 notice of intent to sell 225,000 shares of Protagonist Therapeutics (PTGX) through J.P. Morgan Securities, with an estimated aggregate market value of approximately $33.6 million based on the filing date. This represents a large proposed sale relative to Patel's remaining holdings of ~64.7 million shares, but the CEO's intent to sell a meaningful stake signals potential insider distribution at a $9.4B market cap company.
- CEO Dinesh Patel filed Form 144 to sell 225,000 shares of PTGX common stock.
- Estimated aggregate market value of the proposed sale is $33,583,500.
- Patel holds approximately 64,708,285 shares after the proposed sale (post-sale holdings).
- The shares to be sold were acquired via option exercise on August 10, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access